1 2 3 4
читать далее ... ysiology of dialysis hypotension: An update. Am. J. Kidney Dis. 2001; 38: S11-S17. 2. Schreiber M. J. Clinical dilemmas in dialysis: Managing the hypotensive patient setting the stage. Ibid. S1—S10. 3. Misra M., Vonesh E., Van Stone J. C. et al. Effect of cause and time of dropout on the residual GFR: A comparative analysis of the decline of GFR on dialysis. Kidney Int. 2001; 59: 754— 763. 4. Leypoldt J. К., Cheung А. К., Steuer R. R. et al. Determination of circulating blood volume by continuously monitoring hematocrit during hemodialysis. J. Am. Soc. Nephrol. 1995; 6: 214-219.5. John A. S., Tueiff S. D., Kerstein M. D. Nonocclusive mesenteric infarction in hemodialysis patients. J. Am. Coll. Surg. 2000; 190: 84—88. 6. Foley R. N., Palfrey P. S., Kent G. M. et al. Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int. 1998; 54: 1720-1725. 7. Krepel H. P., Nette R. W., Akcahuseym E. et a). Variability of relative blood volume during hemodialysis. Nephrol. Dial. Transplant. 2000; 15: 673-679. 8. Foley R. N.. Parfrey P. S., Hamett J. D. et al. The impact of anemia on cardiomyopathy, morbidity, and mortality in endstage renal disease. Am. J. Kidney Dis. 1996; 28: 53—61. 9. Locatelli F., Marcelli D., Conte F. et al. Cardiovascular disease in chronic renal failure: the challenge continues. Nephrol. Dial. Transplant. 2000; 15(suppl. 5): 69—80. 10. Madore F., Lowrie E. G., Brugnara C. et al. Anemia in hemodialysis patients: variables affecting this outcome predictor. J. Am. Soc. Nephrol. 1997; 8: 1921-1929.Источник: Милованова Л.Ю. и др. Терапевтический архив. 2003. №6. С.50-53